So-Young International Achieves Compliance with Nasdaq's Pricing Requirements

So-Young International's Successful Compliance Regaining

On July 3, 2025, So-Young International Inc. (Nasdaq: SY), a leader in China's aesthetic treatment sector, announced it has complied with the Nasdaq minimum bid price requirement following a notification from the Listing Qualifications Department. The company received this confirmation on July 2, 2025, signifying its shares' closing bid price have sustained above the required $1.00 for ten consecutive business days.

This announcement marks a significant turnaround for So-Young, which faced compliance issues following a notification from Nasdaq on August 28, 2024, when its American depositary shares (ADSs) fell below the $1.00 threshold for 30 continuous business days, triggering a compliance period of 180 calendar days. Subsequently, on February 25, 2025, So-Young was granted an extension of an additional 180 days to meet the requirement deadline. With determination and strategic planning, the company has achieved compliance ahead of this new deadline on August 25, 2025.

For the period between June 17 to July 1, 2025, So-Young's ADSs have successfully traded at prices of $1.00 per share or higher, leading to Nasdaq’s determination that the company has regained compliance. The completion of this compliance reinstates investor confidence, as Nasdaq has now closed the issue regarding So-Young's stock performance.

So-Young's business model is predicated on connecting consumers to aesthetic treatments through an innovative online platform alongside its branded aesthetic centers. With a solid reputation, the company simplifies access to aesthetic options, promoting a variety of high-quality treatments. This encompasses facilities for online bookings, curated treatment information, and the distribution of advanced medical equipment and injectable products, positioning So-Young favorably in the expanding aesthetics sector.

The management team at So-Young remains committed to upholding its strong market presence and providing superior aesthetic services driven by technology and consumer insights. The company’s adaptable strategies have shown promising results, allowing it to navigate challenges and extend its market reach effectively.

So-Young’s senior leadership expressed optimism about the future growth trajectories, reinforcing their belief in the value of medical aesthetic treatments. In their latest assessment, the team noted the growing consumer demand in China’s expanding market for aesthetic services.

This compliance achievement stands as a notable milestone in So-Young's ongoing journey to enhance its brand and expand its digital footprint in the healthcare domain. Going forward, the company aims to capitalize on its current momentum to foster growth, build infrastructure, and improve customer engagement through new innovations and partnerships.

In conclusion, So-Young International’s successful compliance with Nasdaq's minimum bid price requirement not only emphasizes its resilience but also marks a pivotal point in its continued dedication to leading the aesthetic treatment industry, showcasing the company’s strong performance and potential to adapt and thrive in a competitive market landscape.